Search research articles
Contact Us
Filters
Showing results (31-40 of 35) with videos related to
Page
of 4
Sort By:
You have reached the last page of results.
This site can display upto 35 results.
Reports of Practical Oncology and Radiotherapy : Journal of Greatpoland Cancer Center in Poznan and Polish Society of Radiation Oncology
|
June 2, 2020
Long-term outcome comparison for standard fractionation (>59 Gy) versus hyperfractionated (>45 Gy) radiotherapy plus concurrent chemotherapy for limited-stage small-cell lung cancer
John M Watkins, J Kyle Russo, Nicholas Andresen, et al.
Pathology Oncology Research : POR
|
October 29, 2017
Is More Always Better? An Assessment of the Impact of Lymph Node Yield on Outcome for Clinically Localized Prostate Cancer with Low/Intermediate Risk Pathology (pT2-3a/pN0) Managed with Prostatectomy Alone
Steven N Seyedin, Darrion L Mitchell, Sarah L Mott, et al.
Advances in Radiation Oncology
|
December 22, 2021
A Recursive Partitioning Analysis Demonstrating Risk Subsets for 8-Year Biochemical Relapse After Margin-Positive Radical Prostatectomy Without Adjuvant Hormone or Radiation Therapy
Steven N Seyedin, John M Watkins, Zachary Mayo, et al.
Journal of Oncology Translational Research
|
December 17, 2016
Once Daily High-dose Radiation (≥60 Gy) Treatment in Limited Stage Small Cell Lung Cancer
Amir Zahra, Tangel Chang, Taher Abu Hejleh, et al.
Archives of Surgery (Chicago, Ill. : 1960)
|
July 14, 2004
Pancreaticoduodenectomy: a 20-year experience in 516 patients
C Max Schmidt, Emilie S Powell, Constantin T Yiannoutsos, et al.
Page
of 4
Search research articles
Search
Showing results (31-40 of 35) with videos related to
Sort By:
Page
of 4
You have reached the last page of results.
This site can display upto 35 results.
Reports of Practical Oncology and Radiotherapy : Journal of Greatpoland Cancer Center in Poznan and Polish Society of Radiation Oncology
|
June 2, 2020
Long-term outcome comparison for standard fractionation (>59 Gy) versus hyperfractionated (>45 Gy) radiotherapy plus concurrent chemotherapy for limited-stage small-cell lung cancer
John M Watkins, J Kyle Russo, Nicholas Andresen, et al.
Pathology Oncology Research : POR
|
October 29, 2017
Is More Always Better? An Assessment of the Impact of Lymph Node Yield on Outcome for Clinically Localized Prostate Cancer with Low/Intermediate Risk Pathology (pT2-3a/pN0) Managed with Prostatectomy Alone
Steven N Seyedin, Darrion L Mitchell, Sarah L Mott, et al.
Advances in Radiation Oncology
|
December 22, 2021
A Recursive Partitioning Analysis Demonstrating Risk Subsets for 8-Year Biochemical Relapse After Margin-Positive Radical Prostatectomy Without Adjuvant Hormone or Radiation Therapy
Steven N Seyedin, John M Watkins, Zachary Mayo, et al.
Journal of Oncology Translational Research
|
December 17, 2016
Once Daily High-dose Radiation (≥60 Gy) Treatment in Limited Stage Small Cell Lung Cancer
Amir Zahra, Tangel Chang, Taher Abu Hejleh, et al.
Archives of Surgery (Chicago, Ill. : 1960)
|
July 14, 2004
Pancreaticoduodenectomy: a 20-year experience in 516 patients
C Max Schmidt, Emilie S Powell, Constantin T Yiannoutsos, et al.
Page
of 4